febuxostat Supplier - Clearsynth Canada INC

febuxostat

Description :

Xanthine oxidase/xanthine dehydrogenase inhibitor. Used for treatment of hyperuricemia and chronic gout. 40-120 mg/day febuxostat was proven effective in lowering serum urate levels when administered to manage hyperuricemia in patients with gout.

Seller Info :

Clearsynth Canada INC

Product Details :

Cas Number144060-53-7

Categories :

Research Chemicals
About Suppliers :
Clearsynth Canada INC

Clearsynth is a technology based, research driven enterprise with the World's Largest Inventory of Reference Standards & Research Chemicals. Clearsynth aim to enable the research community in accelerated Read More..

www.worldofchemicals.com uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X